A recent study has also shown that the ratio between C-terminally truncated tau368 and t-tau is significantly decreased in patients with Alzheimer’s disease, with a strong correlation with 18F-GTP1 retention in brain [207] (a measure of tangle pathology in vivo); these data suggest that tau fragment may preferentially accumulate in tangles, and the CSF ratio tau368/t-tau reflects tangle pathology in brain and can be used as an additional tau biomarker to stage and improve the diagnosis of Alzheimer’s disease. This evidence concerns the gene MAPT and Alzheimer disease.